3,578 reports of this reaction
3.4% of all METFORMIN HCL reports
#4 most reported adverse reaction
DIARRHOEA is the #4 most commonly reported adverse reaction for METFORMIN HCL, manufactured by Ascend Laboratories, LLC. There are 3,578 FDA adverse event reports linking METFORMIN HCL to DIARRHOEA. This represents approximately 3.4% of all 105,459 adverse event reports for this drug.
Patients taking METFORMIN HCL who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is moderately reported among METFORMIN HCL users, representing a notable but not dominant share of adverse events.
In addition to diarrhoea, the following adverse reactions have been reported for METFORMIN HCL:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 3,578 FDA reports for METFORMIN HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 3.4% of all adverse event reports for METFORMIN HCL, making it a notable side effect.
If you experience diarrhoea while taking METFORMIN HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.